Clinical Trials
37 trialsMC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
Mayo Clinic
Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
NAET4-SNACC
Eye & ENT Hospital of Fudan University
EIC-SNACC
Eye & ENT Hospital of Fudan University
MRG003-SACC
Eye & ENT Hospital of Fudan University
Amivantamab in Adenoid Cystic Carcinoma
University of Cincinnati
Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
M.D. Anderson Cancer Center
ANTARES
Instituto do Cancer do Estado de São Paulo
STRAP
National Cancer Centre, Singapore
A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
Memorial Sloan Kettering Cancer Center
An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma
Mayo Clinic
Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
I-MAC
Dana-Farber Cancer Institute
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma
Dana-Farber Cancer Institute
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
Memorial Sloan Kettering Cancer Center
LuRM_ACC/2023
Maria Sklodowska-Curie National Research Institute of Oncology
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
M.D. Anderson Cancer Center
ACCO
Heidelberg University
LUPSA
Radboud University Medical Center
Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma
Qingdao Central Hospital
A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma
Dana-Farber Cancer Institute
Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Dana-Farber Cancer Institute
Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)
Fudan University
Cabo ASAP
Radboud University Medical Center
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck
University of Iowa
ACC
University of Virginia
Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma
Shanghai Proton and Heavy Ion Center
A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
University of Pittsburgh
A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
University Health Network, Toronto
ACCRAD001
Seoul National University Hospital
Dovitinib in Adenoid Cystic Carcinoma
Seoul National University Hospital
Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck
Gustave Roussy, Cancer Campus, Grand Paris